Susana Perez-Gutthann
011-34932417760

Susana Perez-Gutthann

Vice President, Global Head Epidemiology, RTI Health Solutions

Susana Perez-Gutthann, MD, MPH, PhD, FISPE, FRCP, leads a team of over 30 epidemiologists and research staff, including senior experts, in the field of pharmacoepidemiology and risk management in RTP (NC, US), Waltham (MA, US), and Barcelona (Spain). Prior positions include global and European head of epidemiology at Pfizer, Pharmacia, Novartis, and Ciba-Geigy.

Dr. Perez-Gutthann has over 24 years of experience leading epidemiology teams, and strategy and research programs for safety, pharmacovigilance, risk management, and drug development. She is an active leader and past president of the International Society of Pharmacoepidemiology (ISPE); a Fellow of ISPE and of the Royal College of Physicians, Edinburgh; and represents RTI Health Solutions at the European Network of Centres for Pharmacoepidemiology and Pharmacovigilance, where she has served as member of the steering group since 2011.

Dr. Perez-Gutthann is the principal investigator of studies and serves as chair or member of advisory boards in pharmacoepidemiology and risk management.

Education

MD, PhD, Universitat de Barcelona; MPH (Postdoctoral fellowship), Epidemiology, The Johns Hopkins University.

Latest Publications

Curtis, J.R., Perez-Gutthann, S., Suissa, S., Napalkov, P., Singh, N., Thompson, L., et al. (2015). Tocilizumab in rheumatoid arthritis: A case study of safety evaluations of a large postmarketing data set from multiple data sources. Semin Arthritis Rheum , 44 (4):381-388.
Moride, Y., Andrews, E., Perez-Gutthann, S., Soriano-Gabarro, M., Heaton, S., Suzart-Woischnik, K., et al. (2014). Challenges in Risk Minimization Evaluation: CIOMS Working Group IX Consensus and Recent Field Experience, Pharmacoepidemiology and Drug Safety, 23 (Suppl. 1):41-42.
Hazell, L., Pladevall-Vila, M., Scotti, L., De Beradis, G., Varas-Lorenzo, C., Perez-Gutthann, S., et al. (2014). Diabetes drugs and acute pancreatitis: A systematic review of observational studies, Pharmacoepidemiology and Drug Safety, 23 (Suppl. 1):277-277.
Margulis, A.V., Pladevall, M., Riera-Guardia, N., Varas-Lorenzo, C., Hazell, L., Berkman, N.D., Viswanathan, M., & Perez-Gutthann, S. (2014). Quality assessment of observational studies in a drug-safety systematic review, comparison of two tools: the Newcastle-Ottawa Scale and the RTI item bank. Clinical Epidemiology, 6 :359-368.
Varas-Lorenzo, C., Margulis, A.V., Pladevall, M., Riera-Guardia, N., Calingaert, B., Hazell, L., Romio, S., & Perez-Gutthann, S. (2014). The risk of heart failure associated with the use of noninsulin blood glucose-lowering drugs: systematic review and meta-analysis of published observational studies. BMC Cardiovascular Disorders, 14 :Article No. 129.
View all publications by Susana Perez-Gutthann (73)

Expertise

  • Pharmacoepidemiology
  • Drug Safety
  • Risk Management
  • Epidemiology